PDS Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.About PDSB
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection.
CEOFrank K. Bedu-Addo
CEOFrank K. Bedu-Addo
Employees26
Employees26
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2005
Founded2005
Employees26
Employees26
PDSB Key Statistics
Market cap137.57M
Market cap137.57M
Price-Earnings ratio-2.78
Price-Earnings ratio-2.78
Dividend yield—
Dividend yield—
Average volume1.17M
Average volume1.17M
High today$4.56
High today$4.56
Low today$3.85
Low today$3.85
Open price$3.91
Open price$3.91
Volume854.31K
Volume854.31K
52 Week high$10.27
52 Week high$10.27
52 Week low$3.61
52 Week low$3.61
PDSB News
TipRanks 1d
Options Volatility and Implied Earnings Moves Today, March 27, 2024Today, several major companies are expected to report earnings: Carnival (CCL), Cintas (CTAS), Durect (DRRX), Altimmune (ALT), RH (RH), GlycoMimetics (GLYC), Ch...